Related Experiment Video
Updated: Apr 15, 2026
07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.7K
PICan: An integromics framework for dynamic cancer biomarker discovery
Darragh G McArt1, Jaine K Blayney1, David P Boyle1
1Centre for Cancer Research and Cell Biology (CCRCB), Queen's University Belfast, Belfast, United Kingdom.
Molecular Oncology
|March 28, 2015
Summary
Integrating high-throughput data with clinical information is crucial for cancer biomarker discovery. Our novel methods successfully identified TP53 and PICan relevance across DNA, RNA, and protein levels, aiding patient stratification.
Area of Science:
- Oncology
- Bioinformatics
- Genomics
Background:
- Cancer research requires integrating high-throughput data with clinical and epidemiological information for biomarker discovery.
- Existing methods often fail to effectively combine diverse datasets, limiting biomarker identification and patient stratification.
Purpose of the Study:
- To develop and validate a novel approach for integrating phenomic, genomic, and clinical data.
- To facilitate the discovery of new cancer biomarkers and improve patient stratification.
Main Methods:
- Development of a novel computational approach and methods for data integration.
- Interrogation of integrated datasets to identify biological and clinical relevance.
- Application to a known cancer paradigm (TP53, PICan) to validate the approach.
Main Results:
- Successfully integrated phenomic, genomic, and clinical data.
- Recapitulated known biomarker status and prognostic significance of TP53 and PICan.
- Demonstrated relevance at DNA, RNA, and protein levels.
Conclusions:
- The developed integration approach is effective for cancer biomarker discovery.
- This method aids in identifying prognostic and predictive biomarkers for patient stratification.
- Integrated data analysis is key to advancing precision oncology.
